AGN argenica therapeutics limited

News: AGN Argenica Therapeutics Partners With Linear Clinical Research For Phase 1 Clinical Trial

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    Sept 30 (Reuters) - Argenica Therapeutics Ltd (AGN) :

    • ARGENICA PARTNERS WITH LINEAR CLINICAL RESEARCH FOR PHASE 1 CLINICAL TRIAL
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
32.5¢
Change
0.010(3.17%)
Mkt cap ! $40.46M
Open High Low Value Volume
31.5¢ 32.5¢ 31.5¢ $22.95K 71.65K

Buyers (Bids)

No. Vol. Price($)
1 38 32.5¢
 

Sellers (Offers)

Price($) Vol. No.
33.0¢ 20000 1
View Market Depth
Last trade - 11.55am 16/09/2025 (20 minute delay) ?
AGN (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.